Pipeline Phase Listing Configuration


Therapetic Area : bms:therapeutiic-area/solid-tumors

Tumor : bms:tumor/lung

Brand Compound Name :

OPDIVO®
(nivolumab) +
YERVOY®
(ipilimumab)

Pipeline Phase Listing Content

Researches and their phases:::

Phase:
bms:phase/phase-3

Research Area/Line of Therapy

NSCLC EGFR Mutant

Researches and their phases:::

Phase:
bms:phase/phase-3

Research Area/Line of Therapy

NSCLC: 1st line

Researches and their phases:::

Phase:
bms:phase/phase-3

Research Area/Line of Therapy

Unresectable NSCLC